Webinar | How Will Microbiome Reshape Anti-Aging Skin Care in 2026 Register Here

METHYS Dx

METHYS Dx develops methylation marker panels for ctDNA characterization in liquid biopsies, focusing on non-invasive cancer monitoring.
2021
11-50
Paris, Ile-de-France, France

Investment Funding

Revenue

$1M to $10M

Something missing or incorrect on this page? Help us enrich this information